China Cancer Test Market 2017-2022 by Volume, Fore

Dublin, Oct. 13, 2017 (GLOBE NEWSWIRE) -- The "China Cancer Test Market, Volume, Forecast (By Male & Female), Mortality & 26 Cancer (Oncology) Types Market & Volume to 2022" report has been added to Research and Markets' offering.

By the end of year 2022, China Cancer Test Market is expected to cross US$ 24 Billion

China is the leading consumer of tobacco in the worldwide. Urban and Rural areas face high death rate due to the massive impact of growing cancer diseases in China. In order to alleviate cancer prevalence; the government focuses on several Cancer Control Programs which include prevention, early diagnosis and treatment. Early diagnosis programs include screening for breast and cervix cancer while prevention programs such as anti-smoking campaigns and immunization against hepatitis. Public awareness of cancer and the promotion of healthy lifestyle have also been carried out actively. In this report, we have studied in-depth analysis of 26 types of cancer in which Lung cancer is leading the market because China has high consumer of tobacco in worldwide. China has an exceptional number of lung cancer diagnoses and deaths than any other part of the world. Cancer is one of the most significant public health burdens in China. The problem will keep moving in near future as China' air pollution goes mostly unchecked. Lung Cancer leads the China Oncology Market In China, Lung cancer leads the market in both genders. The report covers the different types of cancers and emphasis on genders. Therefore, the categorization was as follows: In Male: Lung Cancer is the most predominant cancer and is mainly driven by adult males, half of Chinese men are expected to be current smokers compared to women, followed by Colorectal Cancer, Liver Cancer, Brain, CNS, Esophageal Cancer and Breast Cancer (not in same chorological order). In Female: Lung cancer cases are less in women as compared to men but other cancers were Liver and Breast Cancer, Uterus and Ovarian Cancer are other most common cancers. Some other Cancers studied in this report are Lip, Oral Cavity, & Pharynx, Nasopharynx, Pancreas, Bone, Prostate, Luekemia, Bladder, Kidney and Lymphoma Soaring Cancer Mortality Rates Over the past three decades, Cancer Mortality Rates in China have been rising rapidly. In the urban region, the mortality of cancer is comparatively higher than in rural one. Out of 26 Types of Cancer studied in the report, Lung cancer accounts for the highest fatalities, followed by Digestive Tract Cancers (Stomach, Liver Cancer, Esophageal and Colorectum Cancer). China Cancer Test Market, Volume, Forecast (By Male & Female), Mortality & 26 Cancer (Oncology) Types Market & Volume to 2022 studies the oncology market in China. This 357 page report with 314 Figures and 12 Tables provides in-depth analysis of China Cancer Tests Market and Volume. All 26 types of cancer in the report have been analyzed from 3 major viewpoints which further study it from 2 different perspectives. 1. China Cancer (Oncology) Screening Tests Market & Forecast

• Male
• Female

2. China Cancer (Oncology) Screening Tests Volume & Forecast

• Male
• Female

3. China Cancer (Oncology) Mortality Rate All the 26 Cancer Market & Cases Studied in the Report are as Follows: 1. Lip, oral cavity, & pharynx (except nasopharynx) 2. Nasopharynx 3. Esophagus 4. Stomach 5. Colorectum 6. Liver 7. Gallbladder 8. Pancreas 9. Larynx 10. Lung 11. Other thoracic organs 12. Bone 13. Melanoma of the skin 14. Breast 15. Cervix 16. Uterus 17. Ovary 18. Prostate 19. Testis 20. Kidney 21. Bladder 22. Brain, CNS 23. Thyroid 24. Lymphoma 25. Leukemia 26. All other sites and unspecified

Key Topics Covered:

1 Research Findings 2 China - Cancer Test Market (2010 - 2022) 2.1 Male - Cancer Test Market & Forecast 2.2 Female - Cancer Test Market & Forecast 3 China - Cancer Test Volume (2010 - 2022) 3.1 Male - Cancer Test Volume & Forecast 3.2 Female - Cancer Test Volume & Forecast 4 China - Cancer Test Market Share (2010 - 2022) 4.1 Male - Cancer Test Market Share & Forecast 4.2 Female - Cancer Test Market Share & Forecast 5 China Oncology Test Market Share - Male Vs Female 6 China - Cancer Test Volume Share (2010 - 2022) 6.1 Male - Cancer Test Volume Share & Forecast 6.2 Female - Cancer Test Volume Share & Forecast 7 China Oncology Test Volume Share - Male Vs Female 8 China - Cancer Test Market (2010 - 2022) 8.1 Lip, Oral Cavity, & Pharynx (except Nasopharynx) Cancer Test Market & Forecast 8.1.1 Male - Lip, Oral Cavity, & Pharynx (except Nasopharynx) Cancer Test Market 8.1.2 Female - Lip, Oral Cavity, & Pharynx (except Nasopharynx) Cancer Test Market 8.2 Nasopharynx Cancer Test Market & Forecast 8.2.1 Male - Nasopharynx Cancer Test Market 8.2.2 Female - Nasopharynx Cancer Test Market 8.3 Esophagus Cancer Test Market & Forecast 8.3.1 Male - Esophagus Cancer Test Market 8.3.2 Female - Esophagus Cancer Test Market 8.4 Stomach Cancer Test Market & Forecast 8.4.1 Male - Stomach Cancer Test Market 8.4.2 Female - Stomach Cancer Test Market 8.5 Colorectum Cancer Test Market 8.5.1 Male - Colorectum Cancer Test Market 8.5.2 Female - Colorectum Cancer Test Market 8.6 Liver Cancer Test Market & Forecast 8.6.1 Male - Liver Cancer Test Market 8.6.2 Female - Liver Cancer Test Market 8.7 Gallbladder Cancer Test Market & Forecast 8.7.1 Male - Gallbladder Cancer Test Market 8.7.2 Female - Gallbladder Cancer Test Market 8.8 Pancreas Cancer Test Market & Forecast 8.8.1 Male - Pancreas Cancer Test Market 8.8.2 Female - Pancreas Cancer Test Market 8.9 Larynx Cancer Test Market & Forecast 8.9.1 Male - Larynx Cancer Test Market 8.9.2 Female - Larynx Cancer Test Market 8.10 Lung Cancer Test Market & Forecast 8.10.1 Male - Lung Cancer Test Market 8.10.2 Female - Lung Cancer Test Market 8.11 Other Thoracic Organs Cancer Test Market & Forecast 8.11.1 Male - Other Thoracic Organs Cancer Test Market 8.11.2 Female - Other Thoracic Organs Cancer Test Market 8.12 Bone Cancer Test Market & Forecast 8.12.1 Male - Bone Cancer Test Market 8.12.2 Female - Bone Cancer Test Market 8.13 Melanoma Skin Cancer Test Market & Forecast 8.13.1 Male - Melanoma Skin Cancer Test Market 8.13.2 Female - Melanoma Skin Cancer Test Market 8.14 Breast Cancer Test Market & Forecast 8.14.1 Male - Breast Cancer Test Market 8.14.2 Female - Breast Cancer Test Market 8.15 Cervix Cancer Test Market & Forecast 8.16 Uterus Cancer Test Market & Forecast 8.17 Ovary Cancer Test Market & Forecast 8.18 Prostate Cancer Test Market & Forecast 8.19 Testis Cancer Test Market 8.20 Kidney Cancer Test Market & Forecast 8.20.1 Male - Kidney Cancer Test Market 8.20.2 Female - Kidney Cancer Test Market 8.21 Bladder Cancer Test Market & Forecast 8.21.1 Male - Bladder Cancer Test Market 8.21.2 Female - Bladder Test Market 8.22 Brain, CNS Cancer Test Market & Forecast 8.22.1 Male - Brain, CNS Cancer Test Market 8.22.2 Female - Brain, CNS Cancer Test Market 8.23 Thyroid Cancer Test Market & Forecast 8.23.1 Male - Thyroid Cancer Test Market 8.23.2 Female - Thyroid Cancer Test Market 8.24 Lymphoma Cancer Test Market 8.24.1 Male - Lymphoma Cancer Test Market 8.24.2 Female - Lymphoma Cancer Test Market 8.25 Leukemia Cancer Test Market 8.25.1 Male - Leukemia Cancer Test Market 8.25.2 Female - Leukemia Cancer Test Market 8.26 All Other and Unspecified Test Market 8.26.1 Male - All Other and Unspecified Cancer Test Market 8.26.2 Female - All Other and Unspecified Cancer Test Market 9 China - Oncology Test Volume (2010 - 2022) 9.1 Lip, Oral Cavity, & Pharynx (except Nasopharynx) Cancer Test Volume 9.1.1 Male - Lip, Oral Cavity, & Pharynx (except Nasopharynx) Cancer Test Volume 9.1.2 Female - Lip, Oral Cavity, & Pharynx (except Nasopharynx) Cancer Test Volume 9.2 Nasopharynx Cancer Test Volume 9.2.1 Male - Nasopharynx Cancer Test Volume 9.2.2 Female - Nasopharynx Cancer Test Volume 9.3 Esophagus Cancer Test Volume 9.3.1 Male - Esophagus Cancer Test Volume 9.3.2 Female - Esophagus Cancer Test Volume 9.4 Stomach Cancer Test Volume 9.4.1 Male - Stomach Cancer Test Volume 9.4.2 Female - Stomach Cancer Test Volume 9.5 Colorectum Cancer Test Volume 9.5.1 Male - Colorectum Cancer Test Volume 9.5.2 Female - Colorectum Cancer Test Volume 9.6 Liver Cancer Test Volume 9.6.1 Male - Liver Cancer Test Volume 9.6.2 Female - Liver Cancer Test Volume 9.7 Gallbladder Cancer Test Volume 9.7.1 Male - Gallbladder Cancer Test Volume 9.7.2 Female - Gallbladder Cancer Test Volume 9.8 Pancreas Cancer Test Volume 9.8.1 Male - Pancreas Cancer Test Volume 9.8.2 Female - Pancreas Cancer Test Volume 9.9 Larynx Cancer Test Volume 9.9.1 Male - Larynx Cancer Test Volume 9.9.2 Female - Larynx Cancer Test Volume 9.10 Lung Cancer Test Volume 9.10.1 Male - Lung Cancer Test Volume 9.10.2 Female - Lung Cancer Test Volume 9.11 Other Thoracic Organs Test Volume 9.11.1 Male - Other Thoracic Organs Cancer Test Volume 9.11.2 Female - Other Thoracic Organs Cancer Test Volume 9.12 Bone Cancer Test Volume 9.12.1 Male - Bone Cancer Test Volume 9.12.2 Female - Bone Cancer Test Volume 9.13 Melanoma of the Skin Cancer Test Volume 9.13.1 Male - Melanoma of the Skin Cancer Test Volume 9.13.2 Female - Melanoma of the Skin Cancer Test Volume 9.14 Breast Cancer Test Volume 9.14.1 Male - Breast Cancer Test Volume 9.14.2 Female - Breast Cancer Test Volume 9.15 Cervix Cancer Test Volume 9.16 Uterus Cancer Test Volume 9.17 Ovary Cancer Test Volume 9.18 Prostate Cancer Test Volume 9.19 Testis Cancer Test Volume 9.20 Kidney Cancer Test Volume 9.20.1 Male - Kidney Cancer Test Volume 9.20.2 Female - Kidney Cancer Test Volume 9.21 Bladder Cancer Test Volume 9.21.1 Male - Bladder Cancer Test Volume 9.21.2 Female - Bladder Cancer Test Volume 9.22 Brain, CNS Cancer Test Volume 9.22.1 Male - Brain, CNS Cancer Test Volume 9.22.2 Female - Brain, CNS Cancer Test Volume 9.23 Thyroid Cancer Test Volume 9.23.1 Male - Thyroid Cancer Test Volume 9.23.2 Female - Thyroid Cancer Test Volume 9.24 Lymphoma Cancer Test Volume 9.24.1 Male - Lymphoma Cancer Test Volume 9.24.2 Female - Lymphoma Cancer Test Volume 9.25 Leukemia Cancer Test Volume 9.25.1 Male - Leukemia Cancer Test Volume 9.25.2 Female - Leukemia Cancer Test Volume 9.26 All Other and Unspecified Test Volume 9.26.1 Male - All Other and Unspecified Cancer Test Volume 9.26.2 Female - All Other and Unspecified Cancer Test Volume 10 China - Cancer Deaths (2010 - 2022) 11 China - Cancer Mortality Rate (2015) 11.1 Lip, Oral Cavity, & Pharynx (except Nasopharynx) 11.2 Nasopharynx 11.3 Esophagus 11.4 Stomach 11.5 Colorectum 11.6 Liver 11.7 Gallbladder 11.8 Pancreas 11.9 Larynx 11.1 Lung 11.11 Other Thoracic Organs 11.12 Bone 11.13 Melanoma of the skin 11.14 Breast 11.15 Cervix 11.16 Uterus 11.17 Ovary 11.18 Prostate 11.19 Testis 11.2 Kidney 11.21 Bladder 11.22 Brain, CNS 11.23 Thyroid 11.24 Lymphoma 11.25 Leukemia 11.26 All Other and Unspecified 12 China Healthcare Policies and Reimbursement 12.1 The Healthcare Policies 12.2 China Healthcare Insurance Schemes 12.2.1 NRCMS 12.2.2 UEBMI 12.2.3 URBMI 12.2.4 Private Health Insurance 13 Appendix

For more information about this report visit https://www.researchandmarkets.com/research/f...ancer_test

CONTACT: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 Related Topics: Diagnostics, Oncology